Menu

Filtros : "Financiamento NWO" "IFSC" Removido: "Financiamento FAPERJ" Limpar

Filtros

Refine with date range

  • 1

1 - 5 (5 records)

  • Artigo de periodico

    Challenges of continuous wave EPR of broad signals: the ferritin case (2024)

    Otsuka, Fábio Seiji ; Otaduy, Maria Concepción García ; Nascimento, Otaciro Rangel ; Salmon, Carlos Ernesto Garrido ; Huber, Martina

    Source: Applied Magnetic Resonance. Unidades: IFSC, FFCLRP

    Subjects: FERRIMAGNETISMO, RESSONÂNCIA PARAMAGNÉTICA ELETRÔNICA, FERRO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      OTSUKA, Fábio Seiji et al. Challenges of continuous wave EPR of broad signals: the ferritin case. Applied Magnetic Resonance, v. 55, n. 12, p. 1605-1620 + supplementary information, 2024Tradução . . Disponível em: https://doi.org/10.1007/s00723-024-01719-y. Acesso em: 27 nov. 2025.

    • APA

      Otsuka, F. S., Otaduy, M. C. G., Nascimento, O. R., Salmon, C. E. G., & Huber, M. (2024). Challenges of continuous wave EPR of broad signals: the ferritin case. Applied Magnetic Resonance, 55( 12), 1605-1620 + supplementary information. doi:10.1007/s00723-024-01719-y

    • NLM

      Otsuka FS, Otaduy MCG, Nascimento OR, Salmon CEG, Huber M. Challenges of continuous wave EPR of broad signals: the ferritin case [Internet]. Applied Magnetic Resonance. 2024 ; 55( 12): 1605-1620 + supplementary information.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s00723-024-01719-y

    • Vancouver

      Otsuka FS, Otaduy MCG, Nascimento OR, Salmon CEG, Huber M. Challenges of continuous wave EPR of broad signals: the ferritin case [Internet]. Applied Magnetic Resonance. 2024 ; 55( 12): 1605-1620 + supplementary information.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s00723-024-01719-y

  • Artigo de periodico

    Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors (2023)

    Boby, Melissa L.; Fernandes, Rafaela Sachetto ; Gawriljuk, Victor Oliveira; Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Noske, Gabriela Dias; Oliva, Glaucius ; Rangel, Victor Lopes

    Source: Science. Unidades: IFSC, FCFRP

    Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BOBY, Melissa L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, v. 382, n. 6671, p. eabo7201-1-eabo7201-16 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1126/science.abo7201. Acesso em: 27 nov. 2025.

    • APA

      Boby, M. L., Fernandes, R. S., Gawriljuk, V. O., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., et al. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382( 6671), eabo7201-1-eabo7201-16 + supplementary materials. doi:10.1126/science.abo7201

    • NLM

      Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1126/science.abo7201

    • Vancouver

      Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1126/science.abo7201

  • Artigo de periodico

    SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (2022)

    Jansen, Jitske; Fernandes, Rafaela Sachetto ; Oliveira, Victor Gawriljuk Ferraro; Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Noske, Gabriela Dias; Oliva, Glaucius

    Source: Cell Stem Cell. Unidade: IFSC

    Subjects: CORONAVIRUS, COVID-19, RIM

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      JANSEN, Jitske et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, v. 29, n. 2, p. 217-231 + e1-e8, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.stem.2021.12.010. Acesso em: 27 nov. 2025.

    • APA

      Jansen, J., Fernandes, R. S., Oliveira, V. G. F., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., & Oliva, G. (2022). SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, 29( 2), 217-231 + e1-e8. doi:10.1016/j.stem.2021.12.010

    • NLM

      Jansen J, Fernandes RS, Oliveira VGF, Godoy AS de, Nakamura AM, Noske GD, Oliva G. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids [Internet]. Cell Stem Cell. 2022 ; 29( 2): 217-231 + e1-e8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.stem.2021.12.010

    • Vancouver

      Jansen J, Fernandes RS, Oliveira VGF, Godoy AS de, Nakamura AM, Noske GD, Oliva G. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids [Internet]. Cell Stem Cell. 2022 ; 29( 2): 217-231 + e1-e8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.stem.2021.12.010

  • Artigo de periodico

    Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 (2022)

    Vries, Laura E. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho

    Source: Nature Communications. Unidade: IFSC

    Subjects: PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, ANTIPARASITÁRIOS, MALÁRIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VRIES, Laura E. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, v. 13, p. 2158-1-2158-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-29688-5. Acesso em: 27 nov. 2025.

    • APA

      Vries, L. E., Aguiar, A. C. C., & Guido, R. V. C. (2022). Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, 13, 2158-1-2158-16. doi:10.1038/s41467-022-29688-5

    • NLM

      Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41467-022-29688-5

    • Vancouver

      Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41467-022-29688-5

  • Artigo de periodico

    First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization (2022)

    Gierse, Robin M.; Oerlemans, Rick; Reddem, Eswar R.; Gawriljuk, Victor Oliveira; Alhayek, Alaa; Baitinger, Dominik; Jakobi, Harald; Laber, Bernd; Lange, Gudrun; Hirsch, Anna K. H.; Groves, Matthew R.

    Source: Scientific Reports. Unidade: IFSC

    Subjects: MYCOBACTERIUM TUBERCULOSIS, RESISTÊNCIA MICROBIANA ÀS DROGAS, ANTIBIÓTICOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GIERSE, Robin M. et al. First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization. Scientific Reports, v. 12, p. 7221-1-7221-13, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-11205-9. Acesso em: 27 nov. 2025.

    • APA

      Gierse, R. M., Oerlemans, R., Reddem, E. R., Gawriljuk, V. O., Alhayek, A., Baitinger, D., et al. (2022). First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization. Scientific Reports, 12, 7221-1-7221-13. doi:10.1038/s41598-022-11205-9

    • NLM

      Gierse RM, Oerlemans R, Reddem ER, Gawriljuk VO, Alhayek A, Baitinger D, Jakobi H, Laber B, Lange G, Hirsch AKH, Groves MR. First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization [Internet]. Scientific Reports. 2022 ; 12 7221-1-7221-13.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-022-11205-9

    • Vancouver

      Gierse RM, Oerlemans R, Reddem ER, Gawriljuk VO, Alhayek A, Baitinger D, Jakobi H, Laber B, Lange G, Hirsch AKH, Groves MR. First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization [Internet]. Scientific Reports. 2022 ; 12 7221-1-7221-13.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-022-11205-9
  • 1

1 - 5 (5 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025